1. Home
  2. CDXS vs SES Comparison

CDXS vs SES Comparison

Compare CDXS & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • SES
  • Stock Information
  • Founded
  • CDXS 2002
  • SES 2012
  • Country
  • CDXS United States
  • SES United States
  • Employees
  • CDXS N/A
  • SES N/A
  • Industry
  • CDXS Major Chemicals
  • SES Auto Parts:O.E.M.
  • Sector
  • CDXS Industrials
  • SES Consumer Discretionary
  • Exchange
  • CDXS Nasdaq
  • SES Nasdaq
  • Market Cap
  • CDXS 201.3M
  • SES 226.6M
  • IPO Year
  • CDXS 2010
  • SES N/A
  • Fundamental
  • Price
  • CDXS $2.30
  • SES $0.91
  • Analyst Decision
  • CDXS Buy
  • SES Hold
  • Analyst Count
  • CDXS 2
  • SES 3
  • Target Price
  • CDXS $11.00
  • SES $1.50
  • AVG Volume (30 Days)
  • CDXS 1.0M
  • SES 12.4M
  • Earning Date
  • CDXS 05-14-2025
  • SES 04-24-2025
  • Dividend Yield
  • CDXS N/A
  • SES N/A
  • EPS Growth
  • CDXS N/A
  • SES N/A
  • EPS
  • CDXS N/A
  • SES N/A
  • Revenue
  • CDXS $49,815,000.00
  • SES $7,833,000.00
  • Revenue This Year
  • CDXS $2.41
  • SES $929.56
  • Revenue Next Year
  • CDXS $34.28
  • SES $140.44
  • P/E Ratio
  • CDXS N/A
  • SES N/A
  • Revenue Growth
  • CDXS N/A
  • SES N/A
  • 52 Week Low
  • CDXS $1.90
  • SES $0.20
  • 52 Week High
  • CDXS $6.08
  • SES $2.53
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 44.61
  • SES 53.38
  • Support Level
  • CDXS $2.30
  • SES $0.91
  • Resistance Level
  • CDXS $2.56
  • SES $1.01
  • Average True Range (ATR)
  • CDXS 0.20
  • SES 0.08
  • MACD
  • CDXS -0.01
  • SES -0.01
  • Stochastic Oscillator
  • CDXS 46.67
  • SES 40.71

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About SES SES AI Corporation

SES AI Corp is a developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility (UAM), drones, robotics, Battery Energy Storage Systems (BESS) and other applications. It includes Software and Hardware products that are EV, UAM, Drone, Molecular Universe, and Avatar.

Share on Social Networks: